首页> 外文期刊>Molecular biotechnology >Inclusion of Quality Controls on Leishmaniases Molecular Tests to Increase Diagnostic Accuracy in Research and Reference Laboratories
【24h】

Inclusion of Quality Controls on Leishmaniases Molecular Tests to Increase Diagnostic Accuracy in Research and Reference Laboratories

机译:在利什曼原虫病分子测试中纳入质量控制,以提高研究和参考实验室的诊断准确性

获取原文
获取原文并翻译 | 示例
           

摘要

Early detection of leishmaniases and prompt institution of treatment are paramount for individuals and communities affected by these diseases. To overcome the remaining limitations inherent to molecular methods currently used and to ensure the accuracy of results in leishmaniases diagnosis, two triplex polymerase chain reaction (PCR) assays with quality controls for the reactions were developed. Validity indicators were assessed in 186 dog blood samples from endemic areas in Brazil. The level of agreement between the new tools and their singleplex protocols was assessed by kappa analysis. The triplex PCR for visceral leishmaniasis showed sensitivity (S) = 78.68 %, specificity (E) = 85.29 %, and efficiency (e) = 81.05 %. The cutaneous leishmaniasis protocol showed S = 97.29 %, E = 79.16 %, and e = 90.16 %. Both protocols showed good agreement with gold standards. These new tools enable, in a single reaction, the diagnosis of the diseases and the evaluation of the sample quality and DNA extraction process, thus reducing the cost of reagents and avoiding the eventual need for collecting a second sample.
机译:对受这些疾病影响的个人和社区而言,尽早发现利什曼病和及时进行治疗至关重要。为了克服目前使用的分子方法固有的局限性并确保利什曼病诊断结果的准确性,开发了两种三重聚合酶链反应(PCR)检测方法,并对该反应进行了质量控制。在巴西流行地区的186个犬血样本中评估了有效性指标。通过kappa分析评估了新工具与其单重协议之间的协议级别。用于内脏利什曼病的三重PCR显示灵敏度(S)= 78.68%,特异性(E)= 85.29%,效率(e)= 81.05%。皮肤利什曼病方案显示S = 97.29%,E = 79.16%和e = 90.16%。两种协议都显示出与黄金标准的良好一致性。这些新工具可在单个反应中对疾病进行诊断,并评估样品质量和DNA提取过程,从而降低了试剂成本并避免了最终需要收集第二个样品的麻烦。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号